Testicular Cancer
📧 Sign up to get email alerts when something new happens for Testicular Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating sodium thiosulfate as oto-protection during cisplatin therapy for solid tumors; the study is not yet …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors [Phase 1]
A Phase 1 trial is evaluating adding Pedmark (sodium thiosulfate) to cisplatin chemotherapy to reduce cisplatin-induced hearing loss in men …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial [NA]
A ClinicalTrials.gov update for the Thrive Track trial aimed at managing emotional support for young adults with thyroid cancer, melanoma, a…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer [NA]
This clinical trial compares primary retroperitoneal lymph node dissection (RPLND) with systemic chemotherapy as initial treatment for good-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of miRNA 371 in Patients With Germ Cell Tumors
SWOG Cancer Research Network is studying miRNA-371 in patients with germ cell tumors; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: THERApy De-escalation for TESTicular Cancer
Queen Mary University of London is conducting a trial evaluating therapy de-escalation for seminoma (testicular cancer); recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Navigation Intervention for Adolescent and Young Adult Cancer Survivors [NA]
A Kaiser Permanente-sponsored clinical trial update describes a navigation intervention for adolescent and young adult cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection. [Phase 3]
A Phase 3 clinical trial is ongoing comparing intrathecal morphine versus intravenous methadone for postoperative analgesia after retroperit…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer [NA]
This clinical trial update outlines an ongoing Indiana University study evaluating supportive care needs and intervention preferences among …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Virtual Testis Cancer Lay Support and Survivorship Aim 2 [NA]
This clinical trial update describes a virtual lay support and survivorship program for testicular cancer. The study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy [NA]
This clinical trial update outlines a study comparing sparing the external oblique fascia to standard inguinal orchiectomy for testicular ca…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy [Phase 2]
A single-arm Phase II trial evaluating aspirin for prevention of venous thromboembolism in patients with advanced germ cell tumors receiving…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors [NA]
Duke University is recruiting for a study on symptom management and transitioning to engagement with post-treatment care for adolescent and …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma [Phase 2]
This clinical trial update describes a Phase 2 study of reduced-intensity radio-chemotherapy for stage IIA/IIB seminoma (testicular cancer).…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lymphedema After Urologic Surgery
An update on a clinical trial examining lymphedema after urologic cancer surgery shows the study is currently recruiting for patients with u…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
An international cohort study on testicular cancer (SAG TCCS) is currently recruiting in Switzerland, Austria, and Germany.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer [Phase 3]
A Phase 3 clinical trial compares adjuvant BEP (bleomycin, etoposide, cisplatin) versus carboplatin in Stage I seminomatous testicular cance…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: The TASTY-steering Study [NA]
A clinical trial update indicates that the TASTY-steering Study is currently recruiting for patients with metastatic triple-negative breast …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruit…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of radiation therapy with a DLL3-targeting bispecific T-cell engager in DLL3-expres…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects
The TACkLE study, addressing adverse late effects of chemotherapy in testicular cancer, is currently active but not recruiting participants.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases [Phase 2]
A Phase 2 clinical trial is evaluating primary retroperitoneal lymph node dissection in patients with testicular cancer and limited retroper…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer
This clinical trial examines voiding and erectile function after retroperitoneal lymph node dissection in men with testicular cancer and is …
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
This clinical trial update describes the STANDBY-study, which aims to assess health status and the burden of late effects in very long-term …